AAAAAA

   
Results: 1-12 |
Results: 12

Authors: BENDRISS EK BECHTEL YC PAINTAUD G BRIENTINI MP MANTION G MIGUET JP BENNANI A BECHTEL PR
Citation: Ek. Bendriss et al., ACETYLATION POLYMORPHISM EXPRESSION IN PATIENTS BEFORE AND AFTER LIVER-TRANSPLANTATION - INFLUENCE OF HOST GRAFT GENOTYPES/, Pharmacogenetics, 8(3), 1998, pp. 201-209

Authors: MONEK O PAINTAUD G BECHTEL Y MIGUET JP MANTION G BECHTEL PR
Citation: O. Monek et al., INFLUENCE OF DONOR AND RECIPIENT GENOTYPES ON CYP2D6 PHENOTYPE AFTER LIVER-TRANSPLANTATION - A STUDY OF MUTATIONS CYP2D6(ASTERISK)3 AND CYP2D6(ASTERISK)4, European Journal of Clinical Pharmacology, 54(1), 1998, pp. 47-52

Authors: PAINTAUD G THIBAULT P QUENEAU PE MAGNETTE J BERARD M RUMBACH L BECHTEL PR CARAYON P
Citation: G. Paintaud et al., INTRAINDIVIDUAL VARIABILITY OF PARACETAMOL ABSORPTION KINETICS AFTER A SEMISOLID MEAL IN HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 53(5), 1998, pp. 355-359

Authors: BENDRISS EK BECHTEL Y BENDRISS A HUMBERT P PAINTAUD G MAGNETTE J AGACHE P BECHTEL PR
Citation: Ek. Bendriss et al., INHIBITION OF CAFFEINE METABOLISM BY 5-METHOXYPSORALEN IN PATIENTS WITH PSORIASIS, British journal of clinical pharmacology, 41(5), 1996, pp. 421-424

Authors: MABOUNDOU CW PAINTAUD G BRESSONHADNI S MANTION G MIGUET JP BECHTEL PR
Citation: Cw. Maboundou et al., EFFECT OF THE TRANSITION FROM INTRAVENOUS TO ORAL DOSING ON CYCLOSPORINE - A TROUGH CONCENTRATIONS IN LIVER-TRANSPLANT PATIENTS, Therapeutic drug monitoring, 18(3), 1996, pp. 310-314

Authors: PAINTAUD G BECHTEL Y BRIENTINI MP MIGUET JP BECHTEL PR
Citation: G. Paintaud et al., EFFECTS OF LIVER-DISEASES ON DRUG-METABOLISM, Therapie, 51(4), 1996, pp. 384-389

Authors: MABOUNDOU CW PAINTAUD G VANLEMMENS C MAGNETTE J BRESSONHADNI S MANTION G MIGUET JP BECHTEL PR
Citation: Cw. Maboundou et al., A SINGLE-DOSE OF URSODIOL DOES NOT AFFECT CYCLOSPORINE ABSORPTION IN LIVER-TRANSPLANT PATIENTS, European Journal of Clinical Pharmacology, 50(4), 1996, pp. 335-337

Authors: BENDRISS A BECHTEL Y PAINTAUD G BENDRISS EK JOANNE C BRESSONHADNI S MAGNETTE J BECKER MC GILLET M MANTION G MIGUET JP BECHTEL PR
Citation: A. Bendriss et al., STABILITY OF DEBRISOQUINE (CYP2D6) PHENOTYPE IN LIVER-TRANSPLANT PATIENTS, Therapeutic drug monitoring, 17(2), 1995, pp. 113-119

Authors: CATTEAU A BECHTEL YC POISSON N BECHTEL PR BONAITIPELLIE C
Citation: A. Catteau et al., A POPULATION AND FAMILY STUDY OF CYP1A2 USING CAFFEINE URINARY METABOLITES, European Journal of Clinical Pharmacology, 47(5), 1995, pp. 423-430

Authors: MABOUNDOU CW PAINTAUD G BERARD M BECHTEL PR
Citation: Cw. Maboundou et al., SEPARATION OF 15 NONSTEROIDAL ANTIINFLAMMATORY DRUGS USING MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 657(1), 1994, pp. 173-183

Authors: JOANNE C PAINTAUD G BRESSONHADNI S MAGNETTE J BECKER MC MIGUET JP BECHTEL PR
Citation: C. Joanne et al., IS DEBRISOQUINE HYDROXYLATION MODIFIED DURING ACUTE VIRAL-HEPATITIS, Fundamental and clinical pharmacology, 8(1), 1994, pp. 76-79

Authors: BECHTEL YC BONAITIPELLIE C POISSON N MAGNETTE J BECHTEL PR
Citation: Yc. Bechtel et al., A POPULATION AND FAMILY STUDY OF N-ACETYLTRANSFERASE USING CAFFEINE URINARY METABOLITES, Clinical pharmacology and therapeutics, 54(2), 1993, pp. 134-141
Risultati: 1-12 |